G Bolla

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger et al. · JAMA · 2016 · 189 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Prevalence and Signification of Antinuclear and Anticardiolipin Antibodies in Patients with Epilepsy

D. Verrot, Marielle Sanmarco, Charlotte Dravet et al. · The American Journal of Medicine · 1997 · 101 citations

Medicine, Internal Medicine, Neurology +6

Severe Oral Ulcerations Induced by Alendronate

Nathalie Demerjian, G Bolla, A Spreux · Clinical Rheumatology · 1999 · 76 citations

Dentistry, Oral Medicine, Oral Pathology +8

Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study

Olivier Brocq, E. Acquacalda, F. Berthier et al. · Joint Bone Spine · 2015 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +13